Roxbury Financial’s Tema Oncology ETF CANC Stock Holding History

Roxbury Financial’s Portfolio CANC Stock Details CANC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$182K	Buy	4,325 +385	+10%	+$16.3K	0.14%	104
2026 Q2	$162K	Buy	3,940 +3,016	+326%	+$114K	0.13%	114
2026 Q1	$33.9K	Buy	+924	New	+$33.6K	0.03%	215

Other funds holding CANC

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.92% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

WJ Wealth Management Glendale, Arizona $246M AUM 20.35% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Roxbury Financial's CANC Position: Q3 2026 in Review

Roxbury Financial increased its Tema Oncology ETF (CANC) stake by 9.8% in Q3 2026, buying an estimated $16.3K and bringing the position to 4,325 shares worth $182K. The position accounts for 0.14% of the portfolio, ranked #104.

Roxbury Financial first reported a position in CANC in Q1 2026 and has held it in 3 quarters since. 5 funds tracked by Wall St. Rank hold CANC as of Q3 2026.

Roxbury Financial held 4,325 shares of Tema Oncology ETF worth $182K as of Q3 2026.
Roxbury Financial bought 385 Tema Oncology ETF shares in Q3 2026, an estimated $16.3K.
Tema Oncology ETF made up 0.14% of Roxbury Financial's portfolio in Q3 2026, its #104 holding.
Roxbury Financial first reported a position in Tema Oncology ETF in Q1 2026 and has held it in 3 quarters since.
5 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.

Based on Roxbury Financial's 13F filing for Q3 2026, filed 1 Oct 2026.